![pharmaphorum.com](https://www.pharmaphorum.com/wp-content/uploads/2020/03/Coronavirus-news.jpg)
Moderna begins coronavirus vaccine trial
The US biotech Moderna was just about the only stock on the rise yesterday amid the global COVID-19 bear market, as the Massachusetts firm announced the first patient had been tested with its potential coronavirus vaccine. Moderna is focused on development of vaccines based around mRNA, which...
![pharmaphorum.com](https://pharmaphorum.com/sites/default/files/favicon.png)